CLADRIBINE
Showing 1 - 25 of 172
Leukemia, MDS, Acute Myeloid Leukemia Trial in Houston (Cladribine)
Not yet recruiting
- Leukemia
- +2 more
- Cladribine
-
Houston, TexasM D Anderson Cancer Center
Aug 28, 2023
Acute Myeloid Leukemia, Adult Trial in Hangzhou (cladribine + homoharringtonine + cytarabine)
Recruiting
- Acute Myeloid Leukemia, Adult
- cladribine + homoharringtonine + cytarabine
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital, Zhejiang University School of Med
Jun 13, 2023
Acute Myeloid Leukemia Trial (MCBC regimen, Bu/Cy regimen)
Not yet recruiting
- Acute Myeloid Leukemia
- MCBC regimen
- Bu/Cy regimen
- (no location specified)
Nov 13, 2023
Multiple Sclerosis, Relapsing-Remitting Trial in Porto Alegre (Cladribine 10 mg oral tablet)
Active, not recruiting
- Multiple Sclerosis, Relapsing-Remitting
- Cladribine 10 mg oral tablet
-
Porto Alegre, RS, BrazilPontifical Catholic University of Rio Grande do Sul
Jun 5, 2023
Relapsed Adult AML, Refractory AML Trial in Milwaukee (Navitoclax Dose Level -1, Navitoclax Dose Level 0, Navitoclax Dose Level
Not yet recruiting
- Relapsed Adult AML
- Refractory AML
- Navitoclax Dose Level -1
- +10 more
-
Milwaukee, WisconsinFroedtert Hospital & the Medical College of Wisconsin
Aug 17, 2023
Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis Trial in Warsaw (Cladribine Subcutaneous Injection, 0.9% Chloride
Recruiting
- Multiple Sclerosis, Secondary Progressive
- Multiple Sclerosis
- Cladribine Subcutaneous Injection
- 0.9% Chloride Injection Sodium
-
Warsaw, Mazowieckie, PolandInstitute of Psychiatry and Neurology
Jul 26, 2023
Acute Myeloid Leukemia, MDS Trial (Cladribine, Cytarabine, Decitabine)
Not yet recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- Cladribine
- +4 more
- (no location specified)
Mar 1, 2023
Leukemia Trial in Houston (Cladribine, Cytarabine, Decitabine)
Recruiting
- Leukemia
- Cladribine
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Aug 23, 2022
Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting Trial in Saint Louis (Cladribine)
Recruiting
- Multiple Sclerosis
- Multiple Sclerosis, Relapsing-Remitting
- Cladribine
-
Saint Louis, Missouri
- +4 more
Jan 4, 2023
Acute Lymphoblastic Leukemia Trial in Suzhou (Cladribine, Fludarabine)
Recruiting
- Acute Lymphoblastic Leukemia
- Cladribine
- Fludarabine
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Oct 12, 2022
Acute Myeloid Leukemia Trial in Nanjing (Chidamide, Cladribine)
Recruiting
- Acute Myeloid Leukemia
- Chidamide
- Cladribine
-
Nanjing, Jiangsu, ChinaDepartment of Hematology, Zhongda Hospital Southeast University,
Apr 23, 2022
Microglial Activation in the CNS
Active, not recruiting
- Multiple Sclerosis
- Imaging
-
Turku, Finland Proper, FinlandTurku PET Centre
May 31, 2022
Acute Myeloid Leukemia Trial in Houston (Azacitidine, Cladribine, Cytarabine)
Recruiting
- Acute Myeloid Leukemia
- Azacitidine
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Nov 17, 2022
Acute Myeloid Leukemia Trial (Gilteritinib 40 MG Oral Tablet, Cladribine, Cytarabine)
Not yet recruiting
- Acute Myeloid Leukemia
- Gilteritinib 40 MG Oral Tablet
- +4 more
-
Lexington, KentuckyUniversity of Kentucky
Oct 27, 2022
Acute Lymphoblastic Leukemia Trial in Suzhou (cladribine, cytarabine,venetoclax)
Recruiting
- Acute Lymphoblastic Leukemia
- cladribine, cytarabine,venetoclax
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Dec 22, 2022
MDS, Myeloproliferative Chronic Myelomonocytic Leukemia Trial in Houston (Cladribine, Cytarabine, Venetoclax)
Recruiting
- Myelodysplastic Syndromes
- Myeloproliferative Chronic Myelomonocytic Leukemia
- Cladribine
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Oct 31, 2022
Cladribine Therapy After Anti CD20 Therapy
Active, not recruiting
- Multiple Sclerosis
- Cladribine Oral Tablet
- +2 more
-
Lugano, Ticino, SwitzerlandNeurocenter of Southern Switzerland, Ospedale Regionale di Lugan
Mar 22, 2022
Untreated Adult Acute Myeloid Leukemia Trial in Houston (Cladribine, Guadecitabine, Idarubicin)
Completed
- Untreated Adult Acute Myeloid Leukemia
- Cladribine
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Apr 28, 2022
Acute Myeloid Leukemia, Blasts 20 Percent or More of Bone Marrow Nucleated Cells, High Risk Myelodysplastic Syndrome Trial in
Recruiting
- Acute Myeloid Leukemia
- +7 more
- Cladribine
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Dec 7, 2022
Acute Myeloid Leukemia Trial in Seattle (drug, biological, other)
Active, not recruiting
- Acute Myeloid Leukemia
- Cladribine
- +5 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 10, 2022
Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Houston (procedure, drug, other)
Active, not recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome
- Allogeneic Hematopoietic Stem Cell Transplantation
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Oct 6, 2022
Relapsing Multiple Sclerosis (RMS) Trial in Germany, Poland (Cladribine, Placebo, Microgynon®)
Active, not recruiting
- Relapsing Multiple Sclerosis (RMS)
- Cladribine
- +2 more
-
Bochum, Germany
- +6 more
Feb 8, 2022
Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in
Recruiting
- Acute Biphenotypic Leukemia
- +13 more
- Cladribine
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Jan 19, 2023
Cladribine Tablets in Highly-active Relapsing Multiple Sclerosis
Recruiting
- Relapsing-Remitting Multiple Sclerosis
-
Coventry, United Kingdom
- +7 more
May 20, 2022